← All companies
GLSI
Greenwich LifeSciences, Inc.
$13.54
-0.48 -3.42%
Key statistics
from XBRL data in SEC filingsMarket cap
$199M
Revenue (TTM)
—
Net income (TTM)
-$22.3M
EPS (TTM)
$-1.61
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$10.5M
Total assets
$10.5M
Gross margin
—
52-week range
$7.78 – $34.10
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-03-31
Jun 4, 2026
10-K
Fiscal year ended 2025-12-31
Jun 1, 2026
8-K
Shareholder vote results
Dec 18, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Changed accountants
Jul 24, 2025
10-Q
Quarter ended 2025-03-31
May 20, 2025
10-K
Fiscal year ended 2024-12-31
Apr 15, 2025
8-K
Shareholder vote results
Dec 19, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Entered a material agreement; Unregistered sale of equity
Jun 17, 2024
10-Q
Quarter ended 2024-03-31
May 20, 2024
10-K
Fiscal year ended 2023-12-31
Apr 15, 2024
8-K
Changed accountants
Feb 20, 2024
8-K
Other events
Feb 14, 2024
8-K
Shareholder vote results
Dec 15, 2023
10-Q
Quarter ended 2023-09-30
Oct 19, 2023
10-Q
Quarter ended 2023-06-30
Aug 21, 2023
10-Q
Quarter ended 2023-03-31
May 22, 2023
8-K
Other events
Apr 13, 2023
10-K
Fiscal year ended 2022-12-31
Mar 31, 2023
8-K
Other events
Mar 13, 2023
8-K
Shareholder vote results
Dec 9, 2022
10-Q
Quarter ended 2022-09-30
Nov 14, 2022
10-Q
Quarter ended 2022-06-30
Aug 15, 2022
8-K
Entered a material agreement
Jul 12, 2022
8-K
Other events
Jul 12, 2022
8-K
Other events
Jul 11, 2022
10-K/A
Fiscal year ended 2021-12-31
Jun 24, 2022
10-Q
Quarter ended 2022-03-31
May 20, 2022
10-K
Fiscal year ended 2021-12-31
Mar 21, 2022
8-K
Shareholder vote results
Dec 15, 2021
8-K
Other events
Dec 13, 2021
10-Q
Quarter ended 2021-09-30
Nov 15, 2021
8-K
Regulation FD disclosure
Nov 10, 2021
10-Q
Quarter ended 2021-06-30
Aug 13, 2021
8-K
Other events
Jun 10, 2021
8-K
Other events
Jun 9, 2021
10-Q
Quarter ended 2021-03-31
May 20, 2021